-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Maintains Buy on EyePoint, Raises Price Target to $65

Benzinga·07/01/2026 12:52:58
Listen to the news
Chardan Capital analyst Andreas Argyrides maintains EyePoint (NASDAQ:EYPT) with a Buy and raises the price target from $29 to $65.